IDR 232.0
(1.75%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 497.89 Billion IDR | 46.07% |
2022 | 340.86 Billion IDR | 393.7% |
2021 | -116.05 Billion IDR | -160.2% |
2020 | 192.77 Billion IDR | -54.9% |
2019 | 427.44 Billion IDR | -1.69% |
2018 | 434.77 Billion IDR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 647.58 Billion IDR | -35.13% |
2024 Q1 | 998.28 Billion IDR | 100.5% |
2024 Q3 | -441.85 Billion IDR | 66.37% |
2023 Q2 | 461.76 Billion IDR | 23.12% |
2023 Q1 | 375.04 Billion IDR | 10.03% |
2023 FY | 497.89 Billion IDR | 46.07% |
2023 Q4 | 497.89 Billion IDR | -44.75% |
2023 Q3 | 901.21 Billion IDR | 95.17% |
2022 Q2 | 237.37 Billion IDR | 24.8% |
2022 Q1 | 190.2 Billion IDR | 263.88% |
2022 FY | 340.86 Billion IDR | 393.7% |
2022 Q4 | 340.86 Billion IDR | 22.67% |
2022 Q3 | 277.87 Billion IDR | 17.06% |
2021 FY | -116.05 Billion IDR | -160.2% |
2021 Q4 | -116.05 Billion IDR | 21.3% |
2021 Q3 | -147.47 Billion IDR | -187.41% |
2021 Q2 | 168.71 Billion IDR | -73.0% |
2021 Q1 | 624.98 Billion IDR | 224.21% |
2020 Q4 | 192.77 Billion IDR | 0.0% |
2020 FY | 192.77 Billion IDR | -54.9% |
2020 Q1 | 100.25 Billion IDR | 0.0% |
2019 FY | 427.44 Billion IDR | -1.69% |
2018 FY | 434.77 Billion IDR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
PT Metro Healthcare Indonesia Tbk | 427.86 Billion IDR | -16.366% |
PT Medikaloka Hermina Tbk | 1405.68 Billion IDR | 64.58% |
PT Mitra Keluarga Karyasehat Tbk | -839.7 Billion IDR | 159.294% |
PT Murni Sadar Tbk | 490.08 Billion IDR | -1.594% |
PT Famon Awal Bros Sedaya Tbk | 252.54 Billion IDR | -97.154% |
PT Royal Prima Tbk | -26.49 Billion IDR | 1979.323% |
PT Kedoya Adyaraya Tbk | -57.42 Billion IDR | 967.054% |
PT Sarana Meditama Metropolitan Tbk | 834.93 Billion IDR | 40.367% |
PT Siloam International Hospitals Tbk | -552.3 Billion IDR | 190.149% |
PT Sejahteraraya Anugrahjaya Tbk | 1135.04 Billion IDR | 56.134% |